Search results
Here's Why Merck (MRK) Stock Has Outperformed Industry YTD
Zacks via Yahoo Finance· 1 day agoMerck MRK boasts more than six blockbuster drugs in its portfolio, with PD-L1 inhibitor Keytruda...
AstraZeneca’s $80B sales plan leans on cancer drug expansion
BioPharma Dive via Yahoo Finance· 6 hours agoImfinzi, the company’s flagship immunotherapy, arrived fifth to market in the U.S. and last year...
Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates
Zacks via Yahoo Finance· 4 days agoJ&J JNJ announced that it will acquire a private biotech, Proteologix, which will add the latter’s...
3 Drug Stocks to Watch on Raised 2024 Earnings & Sales Guidance
Zacks via Yahoo Finance· 5 days agoHere we discuss three drugmakers, Eli Lilly and Company (LLY), Novo Nordisk (NVO) and Merck (MRK),...
Intravenous Immunoglobulin (IVIG) Therapy: How It Works and What to Expect
Verywell Health via Yahoo News· 10 hours agoIntravenous Immunoglobulin (IVIG) therapy is a biologic treatment used for immunodeficiencies,...
The Zacks Analyst Blog Highlights Broadcom, Merck, Airbnb, ONEOK and PG&E
Zacks via Yahoo Finance· 6 days agoThe company beat Q1 estimates for earnings and sales. Products like Keytruda and Gardasil have been...
Earnings call: AIM ImmunoTech highlights Q1 2024 progress on cancer trials
Investing.com· 6 days agoAIM ImmunoTech (NYSE: AIM ) Inc. (NYSE American: AIM) provided an optimistic update during its first...
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Benzinga via AOL· 5 days agoOn Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical...
Perioperative Nivolumab Boosts EFS in Resectable Lung Cancer
MedPage Today· 7 days agoCheckMate 77T trial shows 42% reduction in risk of tumor recurrence, progression, or death
Americans Are Spending the Most Money on These 25 Prescription Drugs
Healthline· 6 days agoThe diabetes and weight loss medication semaglutide (Ozempic, Wegovy, and Rybelsus) topped the list....